1-5 of 5
Authors: Daniel D. Karp
Save search
Sort by
Journal Article

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

PDF
Sarina A Piha-Paul and others
The Oncologist, Volume 29, Issue 4, April 2024, Pages e514–e525, https://doi.org/10.1093/oncolo/oyad338
Published: 31 January 2024
Journal Article

A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors

PDF
Blessie Elizabeth Nelson and others
The Oncologist, Volume 28, Issue 12, December 2023, Pages 1100–e1292, https://doi.org/10.1093/oncolo/oyad158
Published: 13 June 2023
Journal Article

Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials

PDF
Ryan W. Huey and others
The Oncologist, Volume 26, Issue 7, July 2021, Pages 588–596, https://doi.org/10.1002/onco.13767
Published: 21 April 2021
Journal Article

Overview of Ocular Side Effects of Selinexor

PDF
Nagham Al-Zubidi and others
The Oncologist, Volume 26, Issue 7, July 2021, Pages 619–623, https://doi.org/10.1002/onco.13756
Published: 08 April 2021
Journal Article

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer

PDF
Reva K. Basho and others
The Oncologist, Volume 23, Issue 11, November 2018, Pages 1300–1309, https://doi.org/10.1634/theoncologist.2017-0498
Published: 23 August 2018